Ticker Details
Ginkgo Bioworks Holdings, Inc.
IPO Date:	September 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$398.17M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 4.54%
Avg Daily Range (30 D):	$0.31 | 4.61%
Avg Daily Range (90 D):	$0.31 | 3.76%

Institutional Daily Volume
Avg Daily Volume:	15.19M
Avg Daily Volume (30 D):	1.1M
Avg Daily Volume (90 D):	.93M

Trade Size
Avg Trade Size (Sh.):	485
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	2,296
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$.97M
Avg Institutional Trade (90 D):	$1M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.59M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.95M
Avg Closing Volume:	60.57K

News

Apr 8, 2026 @ 8:00 PM ProQR Highlights Pipeline Expansion and Multiple U... Source: Proqr Therapeutics N.V.

Sep 23, 2025 @ 4:00 PM A-Alpha Bio Appoints Troy Lionberger as New Chief ... Source: Troy Lionberger

Mar 3, 2025 @ 6:00 PM Global Microbial Fermentation Technology Market to... Source: Delveinsight

Dec 5, 2024 @ 5:53 PM Synthetic Biology Market Forecast: $61.6 Billion b... Source: Bcc Research

Oct 8, 2024 @ 1:00 PM Transforming Healthcare From The Inside Out, Nanor... Source: Tnr, The Niche Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-5.64	$-1.42	$-5.64
Diluted EPS	$-5.64	$-1.42	$-5.64
Revenue	$170.16M	$33.4M	$170.16M
Gross Profit
Net Income / Loss	$-312.76M	$-80.75M	$-312.76M
Operating Income / Loss	$-315.28M	$-70.75M	$-315.28M
Cost of Revenue
Net Cash Flow	$-393.37M	$55.41M	$-393.37M
PE Ratio

Splits
Aug 20, 2024	1:40